Tokunaga Fuminori, Ikeda Fumiyo
Department of Pathobiochemistry, Graduate School of Medicine, Osaka City University, Osaka, Japan.
Medical Institute of Bioregulation, Kyushu University, Fukuoka, Japan.
Biochem Soc Trans. 2022 Apr 29;50(2):799-811. doi: 10.1042/BST20211078.
Ubiquitin regulates numerous aspects of biology via a complex ubiquitin code. The linear ubiquitin chain is an atypical code that forms a unique structure, with the C-terminal tail of the distal ubiquitin linked to the N-terminal Met1 of the proximal ubiquitin. Thus far, LUBAC is the only known ubiquitin ligase complex that specifically generates linear ubiquitin chains. LUBAC-induced linear ubiquitin chains regulate inflammatory responses, cell death and immunity. Genetically modified mouse models and cellular assays have revealed that LUBAC is also involved in embryonic development in mice. LUBAC dysfunction is associated with autoimmune diseases, myopathy, and neurodegenerative diseases in humans, but the underlying mechanisms are poorly understood. In this review, we focus on the roles of linear ubiquitin chains and LUBAC in immune and neurodegenerative diseases. We further discuss LUBAC inhibitors and their potential as therapeutics for these diseases.
泛素通过复杂的泛素密码调控生物学的多个方面。线性泛素链是一种非典型密码,形成独特结构,远端泛素的C末端尾巴与近端泛素的N末端Met1相连。迄今为止,线性泛素链组装复合体(LUBAC)是唯一已知的特异性生成线性泛素链的泛素连接酶复合体。LUBAC诱导的线性泛素链调节炎症反应、细胞死亡和免疫。基因改造小鼠模型和细胞试验表明,LUBAC也参与小鼠胚胎发育。LUBAC功能障碍与人类自身免疫性疾病、肌病和神经退行性疾病有关,但其潜在机制尚不清楚。在本综述中,我们重点关注线性泛素链和LUBAC在免疫和神经退行性疾病中的作用。我们还讨论了LUBAC抑制剂及其作为这些疾病治疗药物的潜力。